Physician profile
Michael B Burris
NPI 1417271198
$6,950.41
in general payments reported to CMS, 2019-2025
40 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,956 · 2020: $1,169 · 2021: $766 · 2022: $1,051 · 2023: $450 · 2024: $370 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623 · Travel and Lodging: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.81 |
| Travel and Lodging | $385.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,723.21 | 2021-2025 | Interstim, Altaviva |
| Medtronic USA, INC. | $1,517.99 | 2019-2020 | |
| Abbvie INC. | $634.75 | 2019-2024 | Lupron Depot |
| Teleflex LLC | $546.88 | 2021-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $297.16 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Pfizer INC. | $285.02 | 2019-2023 | |
| Neotract INC. | $276.91 | 2019-2020 | |
| Boston Scientific Corporation | $273.07 | 2019-2023 | Rezum Generator |
| Endo Pharmaceuticals INC. | $180.16 | 2019-2023 | Xiaflex, Aveed, Edex |
| Janssen Biotech, INC. | $170.32 | 2019-2025 | Erleada |
| Antares Pharma, INC. | $97.32 | 2019-2022 | |
| Travere Therapeutics, INC. | $68.77 | 2019-2021 | |
| Olympus America INC. | $64.43 | 2023-2024 | Itind System |
| Laborie Medical Technologies Corp. | $61.32 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $61.24 | 2020-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.